Skip to Main Content

Paper Details

Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial.
J Am Acad Dermatol
170
2020
AD, Children, Conjunctivitis, Eczema, TCS, atopic dermatitis, children, dupilumab, patients
Author NameAffiliation
George D YancopoulosRegeneron Pharmaceuticals
Ajay BansalRegeneron Pharmaceuticals
Ajay BansalRegeneron Pharmaceuticals
  • 1 - 3

Datasets

Release 1.2